According to a report by Allied Market Research, the global nephrology drugs market is projected to become worth $23.405 million by 2030. US FDA and European Medicines Agency (EMEA) are moving towards mandating that any new approval shall need a certain percentage of diversity to allow the drug for patient use. This development paired with lower costs of conducting clinical trials for sponsors makes India a desirable location for research. Interventions and diagnostics that are to be marketed in India will need bridge trials for Indian population. Addi¬tionally, the Make-in-India initiative for devices and drugs will drive R&D requiring indigenous drug development in India. Clients in this sector expect a strong medical practice with strong patient numbers, specialized and experienced staff in conducting clinical research, and experts in Nephrology who are KOLs and teachers to others in the field of Nephrology.
Aviruk Chakraborty
CEO, Archeron Clinical
With its hybrid clinical trial strategy that includes both developed and emerging markets, provide clients with a more thorough platform with solutions owing to its experience with AI and IoT platforms
Karishma Rampilla
Director, Cavaxion
A Professional Training and Coaching firm helps young graduates to understand the practical training exposure in the field of clinical research
Anuj Tripathi
Founder, Clini India
Committed to the timely, cost-effective, high quality education in the clinical research domain while maintaining superior levels of communication, accountability and flexibility
Jitesh Nagaria
Founder & CEO, DoloopTech
Accelerate the clinical trial drug development process by providing automated clinical intelligence through AI powered solutions
Anant Agarwal
Founder, Indoriv Clinical
Leverages its expertise in developing a medical database through human specimen biobanking and prospective clinical trials
Divya C. Modi
Founder, MedVigil
A global CRO based in India providing expert pharmacovigilance services to biopharmaceutical, generic pharmaceutical, consumer product, medical device, contract research and more
Maheshvari Patel
Founder, NOVOBLISS Research
A Private Professional consulting firm and Independent Contract Research Organization (CRO) carrying out high performance clinical research and clinical activities
Suman Maarisetty
CEO, Orcimed Life Sciences
A quality driven Clinical Research Organization (CRO) focused on delivering accelerated innovative solutions and reliable scientific services
Dr. Vibhu Dhawan
Director-Clinical Research, Renown Clinical Services
Believes in clinical excellence and improved patient care through Research and Innovation
Hrituraj Singh
Co-Founder, Triomics
Combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, costeffective, high quality clinical trials